Connect with us

Health

InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) Added To CSE25 Index

Published

on

) InMed Pharmaceuticals Inc

InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) reported that the company has been included in the CSE25 Index. The company qualified for the index as one of the 25 largest firms in the CSE Composite Index. On September 18, 2017, the “CSE” reported the launch of a new index constituted of the securities of the largest firms trading on the exchange.

The CSE25 Index marks as a subgroup of the CSE Composite Index. It was introduced in 2015 and comprised almost 50% of the exchange’s listed firms and, according to the CSE, comprises more than 75% of the trading activity on the respective exchange. The new index comprises the top 25 securities by market cap contained in the composite index. As per the CSE, these firms account for more than 50% of the weighting in the leading index and are typically equities that attract notable trading volume.

The details

Earlier, InMed reported that it has retained the consulting services of Ben Paterson, P.E., to help in defining the pathway for the purification, manufacturing and scale-up plans for company’s CBD biosynthesis plan. Paterson has experience of almost four decades in advancing pharmaceutical purification and manufacturing processes.

Paterson expertise comprises first defining processes in the laboratory, then scaling up to commercial and pilot scale. He has performed operation, optimization, troubleshooting, design and construction of both small and large molecule drug facilities counting the E. coli biosynthesis of several products. Paterson brings experience in the easy integration of equipment, biochemistry and process control to define a process at scale.

Eric A. Adams, the CEO and President of InMed, reported that Paterson brings notable experience in different facets of biosynthesis production and facility design. His expertise leading complex capital projects, overseeing equipment and facilities, and interfacing with different stakeholders will be a notable asset to company. Paterson completed his BSc. in Chemical Engineering from renowned Northwestern University.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement